Responsibility for Quality. BMS and Portola shall manufacture and supply Apixaban and PRT064445, respectively, under its own quality system necessary to ensure its compliance with cGMP and applicable regulatory requirements during the Term. For the avoidance of doubt, each Party shall be responsible for the quality of its own compound during the Term.
Appears in 3 contracts
Sources: Clinical Collaboration Agreement, Clinical Collaboration Agreement (Portola Pharmaceuticals Inc), Clinical Collaboration Agreement (Portola Pharmaceuticals Inc)